Searched for
MOLECULAR DIAGNOSTICS
Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue...- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyFrom AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...
- ICMR maps dengue strains nationwide as India eyes vaccine rolloutIndia's first dengue vaccine is nearing rollout as a study maps circulating virus strains. All four dengue serotypes are now circulating si...
- Time to re-look at a not-so-glamorous part of healthcare ecosystem: 4 diagnostics stocks with upside potential of up to 18%When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is ...
- Match Your AI Strategy to Your Organization’s RealityArtificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...
- How small-town India is powering the next startup revolutionIndia's startup revolution is spreading beyond metros, with young innovators from tier-2 and tier-3 cities building scalable solutions. Bet...
- HCG uses AI, patient data to personalise cancer treatment: BS Ajaikumar, founderHealthcare Global Enterprises is using artificial intelligence and patient data. Algorithms are being developed to personalise cancer treat...
- Deeptech startup Enlife bags Rs 6 crore to develop AI blood test for Alzheimer'sThe startup aims to replace costly and invasive scans with an AI-powered diagnostic platform tailored for the Indian population. Enlife on ...
- Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SMEAvience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- Fundamental Radar: Why is Kilpest India poised to test Rs 1,184 in 12 months? Sandeep Raina explainsBrokerage firm Nuvama expects Kilpest India to sustain healthy growth in the molecular diagnostics business, led by product launches, acqui...
- Omicron variant to be detected in 20 minutes by molecular diagnosis testPOSTECH announced on the 10th that a research team led by Professor Lee Jung-wook of the Department of Chemical Engineering has developed m...
- COVID-19 impact: Test-kit makers rue ‘total’ export banMolecular diagnostics companies have expressed concern after the government on Saturday decided to ban export of all diagnostic kits and re...
- At least a week to put testing kits in the market: Molecular diagnostic companiesPrivate molecular diagnostic companies have received licenses to get their tests validated but they cannot sell those kits under the curren...
- Motilal Oswal PE fund to invest up to Rs 240 crore in Molbio DiagnosticsMolbio along with its subsidiary Bigtec Labs, has developed and commercialised Truenat, which is claimed to be the world's first commercial...
Load More
